CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home FAMAR R&D agreed to deliver clinical trial material of the newly developed eye-drop formulation of Active Biotech
News
10 Feb 2021

FAMAR R&D agreed to deliver clinical trial material of the newly developed eye-drop formulation of Active Biotech

Famar R&D - Alcorcon

Famar came in agreement with Active Biotech AB to deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.Famar R&D will provide process development, scale-up, supply of material for pre-clinical local tolerance studies and clinical grade material for use in the clinical studies.
The clinical safety study is expected by H2 2021.

Read more
Mentioned Companies
FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS
View company profile
Related categories
Contract Services - Pre Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical Data Drops Finished Dosage Forms